Volume 20, Number 4—April 2014
Research
Novel Betacoronavirus in Dromedaries of the Middle East, 2013
Table 4
Test, antibody titer | No. (%) positive samples |
---|---|
Indirect immunofluorescence | |
160 | 2 (3.4) |
320 | 12 (20.3) |
640 | 16 (27.1) |
1280 | 11 (18.6) |
2560 | 14 (23.7) |
5120 |
4 (6.8) |
Neutralization antibody test | |
<10 | 1 (1.7) |
10 | 7 (11.9) |
20 | 14 (23.7) |
40 | 28 (47.5) |
80 | 8 (13.6) |
160 | 1 (1.7) |
*MERS-CoV, Middle East respiratory syndrome coronavirus.
1These authors contributed equally to this article.
Page created: February 07, 2014
Page updated: February 07, 2014
Page reviewed: February 07, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.